公开(公告)号：DE59507539D1

公开(公告)日：2000-02-03

申请号：DE59507539

申请日：1995-10-02

Applicant: BASF AG

Inventor： LUBISCH WILFRIED ,  VIERLING MICHAEL ,  BEHL BERTHOLD ,  HOFMANN HANS

IPC: A61K31/495 ,  A61P25/00 ,  A61P43/00 ,  C07D403/04

Abstract: PCT No. PCT/EP95/03902 Sec. 371 Date Mar. 27, 1997 Sec. 102(e) Date Mar. 27, 1997 PCT Filed Oct. 2, 1995 PCT Pub. No. WO90/11922 PCT Pub. Date Apr. 25, 1996Pyrrolyltetrahydrobenzoquinoxalinediones of the formula I I and their tautomeric and isomeric forms, and their physiologically tolerated salts, in which the variables have the meanings stated in the description, and the preparation thereof are described. The novel compounds are antagonists of the glutamate receptor subtypes and are thus suitable for controlling various diseases.

公开(公告)号：SK23099A3

公开(公告)日：1999-08-06

申请号：SK23099

申请日：1997-08-22

Applicant: BASF AG

Inventor： STEINER GERD ,  LUBISCH WILFRIED ,  BACH ALFRED ,  EMLING FRANZ ,  WICKE KARSTEN ,  TESCHENDORF HANS-JURGEN ,  BEHL BERTHOLD ,  KERRRIGAN FRANK ,  CHEETHAM SHARON

IPC: A61K31/435 ,  A61K31/519 ,  A61P25/24 ,  A61P43/00 ,  C07D211/00 ,  C07D239/00 ,  C07D333/00 ,  C07D495/14

Abstract: The invention concerns 3-substituted 3,4,5,6,7,8-hexahydro- pyrid3':4,5]thieno-[2,3-d]pyrimidine derivatives of formula (I), their physiologically acceptable salts and use in the therapy.

公开(公告)号：PL175918B1

公开(公告)日：1999-03-31

申请号：PL30148693

申请日：1993-12-14

Applicant: BASF AG

Inventor： STEINER GERD ,  UNGER LILIANE ,  BEHL BERTHOLD ,  TESCHENDORF HANS-JUERGEN

IPC: C07D209/00 ,  C07D209/52

公开(公告)号：DE59407285D1

公开(公告)日：1998-12-17

申请号：DE59407285

申请日：1994-03-19

Applicant: BASF AG

Inventor： TREIBER HANS-JOERG ,  BEHL BERTHOLD ,  HOFMANN HANS

IPC: A61K31/495 ,  C07D233/61 ,  C07D487/04

公开(公告)号：AU3032397A

公开(公告)日：1998-01-14

申请号：AU3032397

申请日：1997-06-05

Applicant: BASF AG

Inventor： LUBISCH WILFRIED ,  BEHL BERTHOLD ,  HOFMANN HANS-PETER ,  SZABO LASZLO

IPC: C07D403/04 ,  A61K31/495

公开(公告)号：ES2107035T3

公开(公告)日：1997-11-16

申请号：ES93912910

申请日：1993-06-08

Applicant: BASF AG

Inventor： STEINER GERD ,  UNGER LILIANE ,  BEHL BERTHOLD ,  TESCHENDORF HANS-JUERGEN ,  MUNSCHAUER RAINER

IPC: C07D513/04 ,  A61K20060101 ,  A61K31/33 ,  A61K31/395 ,  A61K31/40 ,  A61K31/4045 ,  A61K31/4184 ,  A61K31/505 ,  A61K31/506 ,  A61K31/513 ,  A61K31/517 ,  A61K31/519 ,  A61K31/54 ,  A61K31/542 ,  A61P25/00 ,  A61P25/20 ,  A61P25/22 ,  A61P25/24 ,  A61P43/00 ,  C07D20060101 ,  C07D207/00 ,  C07D209/02 ,  C07D209/52 ,  C07D221/00 ,  C07D239/00 ,  C07D401/04 ,  C07D401/06 ,  C07D401/14 ,  C07D403/00 ,  C07D403/04 ,  C07D403/06 ,  C07D403/14 ,  C07D409/04 ,  C07D409/06 ,  C07D409/14 ,  C07D417/14 ,  C07D471/04 ,  C07D487/04 ,  C07D495/04

Abstract: PCT No. PCT/EP93/01438 Sec. 371 Date Dec. 16, 1994 Sec. 102(e) Date Dec. 16, 1994 PCT Filed Jun. 8, 1993 PCT Pub. No. WO94/00458 PCT Pub. Date Jan. 6, 1994.Abstract of the Disclosure: Compounds of the formula I I where R1, R2, n , R3, A, X, Y and Z have the meanings stated in the description, and the preparation thereof are described. The novel compounds are suitable for controlling diseases , i.e., as neuroleptics, antidepressants, sedatives, hypnotics, CNS protectives or muscle relaxants.

公开(公告)号：BG101407A

公开(公告)日：1997-09-30

申请号：BG10140797

申请日：1997-04-11

Applicant: BASF AG

Inventor： LUBISCH WILFRIED ,  VIERLING MICHAEL ,  BEHL BERTHOLD ,  HOFMANN HANS P

IPC: A61K31/495 ,  A61P25/00 ,  A61P43/00 ,  C07D403/04

Abstract: Pyrrolyl-tetrahydrobenzoquinoxaline diodes having the formula are disclosed, as well as their tautomeric and isomeric forms, their physiologically compatible salts and their preparation. In the formula, the variables have the meanings given in the description. These new compounds are glutamate antagonists useful in the therapy of neurodegenerative diseases.

公开(公告)号：AT157366T

公开(公告)日：1997-09-15

申请号：AT93912910

申请日：1993-06-08

Applicant: BASF AG

Inventor： STEINER GERD ,  UNGER LILIANE ,  BEHL BERTHOLD ,  TESCHENDORF HANS-JUERGEN ,  MUNSCHAUER RAINER

IPC: C07D513/04 ,  A61K20060101 ,  A61K31/33 ,  A61K31/395 ,  A61K31/40 ,  A61K31/4045 ,  A61K31/4184 ,  A61K31/505 ,  A61K31/506 ,  A61K31/513 ,  A61K31/517 ,  A61K31/519 ,  A61K31/54 ,  A61K31/542 ,  A61P25/00 ,  A61P25/20 ,  A61P25/22 ,  A61P25/24 ,  A61P43/00 ,  C07D20060101 ,  C07D207/00 ,  C07D209/02 ,  C07D209/52 ,  C07D221/00 ,  C07D239/00 ,  C07D401/04 ,  C07D401/06 ,  C07D401/14 ,  C07D403/00 ,  C07D403/04 ,  C07D403/06 ,  C07D403/14 ,  C07D409/04 ,  C07D409/06 ,  C07D409/14 ,  C07D417/14 ,  C07D471/04 ,  C07D487/04 ,  C07D495/04

Abstract: PCT No. PCT/EP93/01438 Sec. 371 Date Dec. 16, 1994 Sec. 102(e) Date Dec. 16, 1994 PCT Filed Jun. 8, 1993 PCT Pub. No. WO94/00458 PCT Pub. Date Jan. 6, 1994.Abstract of the Disclosure: Compounds of the formula I I where R1, R2, n , R3, A, X, Y and Z have the meanings stated in the description, and the preparation thereof are described. The novel compounds are suitable for controlling diseases , i.e., as neuroleptics, antidepressants, sedatives, hypnotics, CNS protectives or muscle relaxants.

公开(公告)号：GR3022980T3

公开(公告)日：1997-06-30

申请号：GR970400656

申请日：1997-03-31

Applicant: BASF AG

Inventor： SCHLECKER RAINER ,  TREIBER HANS-JOERG ,  BEHL BERTHOLD ,  HOFMANN HANS PETER

IPC: A61K31/505 ,  A61K31/55 ,  A61P9/10 ,  A61P25/00 ,  A61P25/06 ,  A61P25/08 ,  A61P25/16 ,  A61P25/24 ,  A61P25/28 ,  C07D471/14 ,  C07D487/04 ,  C07D487/14 ,  C07D491/044 ,  C07D491/147 ,  C07D495/14

Abstract: Triazolopyrimidines of the formula I where A, D and X have the meanings stated in the description, and their preparation are described. The novel compounds are suitable for controlling diseases.

公开(公告)号：MX9702226A

公开(公告)日：1997-06-28

申请号：MX9702226

申请日：1995-09-19

Applicant: BASF AG

Inventor： TREIBER HANS-JORG ,  LUBISCH WILFRIED ,  BEHL BERTHOLD ,  HOFMANN HANS PETER

IPC: C07D487/04 ,  A61K31/495

Abstract: Se describen imidazoloquinoxalinonas de la formula (Ver Formula) donde R1-R5, A y B tienen los significados establecidos en la descripcion, y la preparacion de las mismas. Las sustancias novedosas son adecuadas para el control de enfermedades.